Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phathom Pharmaceuticals (PHAT) Treasury Shares: 2022-2025

Historic Treasury Shares for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Sep 2025 value amounting to $19.

  • Phathom Pharmaceuticals' Treasury Shares changed negligibly% to $19 in Q3 2025 from the same period last year, while for Sep 2025 it was $19, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $19 for FY2024, which is negligibly% changed negligibly from last year.
  • As of Q3 2025, Phathom Pharmaceuticals' Treasury Shares stood at $19, which was down 0.00% from $19 recorded in Q2 2025.
  • Phathom Pharmaceuticals' 5-year Treasury Shares high stood at $922,214 for Q1 2022, and its period low was $19 during Q2 2023.
  • For the 3-year period, Phathom Pharmaceuticals' Treasury Shares averaged around $2,912, with its median value being $19 (2025).
  • Data for Phathom Pharmaceuticals' Treasury Shares shows a maximum YoY plummeted of 100.00% (in 2023) over the last 5 years.
  • Quarterly analysis of 4 years shows Phathom Pharmaceuticals' Treasury Shares stood at $254,437 in 2022, then crashed by 99.99% to $19 in 2023, then remained steady at $19 in 2024, then remained steady at $19 in 2025.
  • Its Treasury Shares was $19 in Q3 2025, compared to $19 in Q2 2025 and $19 in Q1 2025.